Skip to content

Investigating the effect of adding Transcranial direct current stimulation (TDCS) to acetaminophen codeine in reducing pain in cancer patients

Investigating the effect of adding Transcranial direct current stimulation (TDCS) to acetaminophen codeine in reducing the pain of cancer patients in Isfahan city in 1401

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220719055496N1
Enrollment
30
Registered
2022-07-26
Start date
2022-08-06
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer related pain. Neoplasm related pain (acute) (chronic)

Interventions

Intervention 1: Intervention group: The pain score of patients in this group is measured at the beginning of the study. Then the patients were treated for pain control with acetaminophen codeine along

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Any type of cancer Suffering from moderate to severe pain caused by cancer based on VAS score (5-10) Informed consent to participate in the study Absence of depressive disorders, bipolar disorders, or psychotic disorders based on DSM-V diagnostic criteria during examination by a psychiatrist and a psychiatric assistant No history of epilepsy and other neurological disorders Absence of pregnancy No addiction to drugs and opium Not having implants in the skull or pacemakers or any other prosthetics No prior exposure to transcranial stimulation treatments

Exclusion criteria

Exclusion criteria: The final stage of cancer Lack of informed consent Aggravation of cancer symptoms and the need for hospitalization during the study Intensification of pain in such a way that it is necessary to prescribe strong narcotics (morphine, methadone, oxycodone, pethidine)

Design outcomes

Primary

MeasureTime frame
Pain score of cancer patients according to VAS (Visual Analog Scale). Timepoint: before the intervention and one week, two weeks, three weeks and four weeks after the intervention. Method of measurement: The pain score of the patients is measured by the Visual Analog Scale ruler.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDorsa Davoodpour

Esfahan University of Medical Sciences

Dorsa.davoodpour@gmail.com+98 31 3786 2350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026